Rich Robert F, Cook W James, Green William R
Department of Microbiology and Immunology and the Norris Cotton Cancer Center, Dartmouth Medical School, 1 Medical Center Drive, Borwell 603 West, Lebanon, New Hampshire 03756, USA.
Virology. 2006 Mar 15;346(2):287-300. doi: 10.1016/j.virol.2005.10.009. Epub 2005 Dec 9.
C57BL/6 (H-2b), but not spontaneous virus-expressing AKR.H-2b congenic, mice generate retrovirus-specific CD8+ CTL responses to the immunodominant Kb-restricted epitope, KSPWFTTL. AKR.H-2b non-responsiveness is mediated by a peripheral tolerance mechanism. When co-cultured with primed B6 antiviral pCTL, AKR.H-2b splenocytes are recognized by the antiviral TcR as "veto" cells, which inhibit by an exquisitely virus-specific, MHC-restricted, veto cell FasL/responder T cell Fas, mediated apoptotic mechanism. Here, AKR.H-2b thymus, lymph node, and bone marrow cells are also shown to inhibit antiviral CTL generation. Purified AKR.H-2b CD4+ and CD8+ T cells, and B cells, served effectively as FasL-dependent veto cells. In contrast, AKR.H-2b dendritic cells (DC) did not efficiently veto antiviral CTL responses, despite expressing sufficient MHC class I/viral peptide complexes for TcR recognition. AKR.H-2b DC also expressed FasL mRNA and cell surface protein, albeit at a lower level than AKR.H-2b T and B cells. These findings suggest a fail-safe escape mechanism by virus-infected cells for escape from CTL-mediated immunity.
C57BL/6(H-2b)小鼠,而非自发表达病毒的AKR.H-2b同源基因小鼠,会针对免疫显性的Kb限制性表位KSPWFTTL产生逆转录病毒特异性CD8 + CTL反应。AKR.H-2b小鼠的无反应性是由外周耐受机制介导的。当与经致敏的B6抗病毒pCTL共培养时,AKR.H-2b脾细胞被抗病毒TcR识别为“否决”细胞,其通过一种高度病毒特异性、MHC限制性的否决细胞FasL/应答T细胞Fas介导的凋亡机制发挥抑制作用。在此,还显示AKR.H-2b胸腺、淋巴结和骨髓细胞也能抑制抗病毒CTL的产生。纯化的AKR.H-2b CD4 +和CD8 + T细胞以及B细胞可有效充当FasL依赖性否决细胞。相比之下,尽管AKR.H-2b树突状细胞(DC)表达了足够用于TcR识别的MHC I类/病毒肽复合物,但它们并不能有效地否决抗病毒CTL反应。AKR.H-2b DC也表达FasL mRNA和细胞表面蛋白,尽管其水平低于AKR.H-2b T细胞和B细胞。这些发现提示病毒感染细胞存在一种故障安全逃逸机制,以逃避CTL介导的免疫反应。